Furans

Medchemexpress LLC 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1h-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine | 873551-53-2 | 99.3% | 358.41 g·mol⁻¹ | C18H23FN6O | 5 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

FTIDC is an orally active, noncompetitive, selective allosteric antagonist of the metabotropic glutamate receptor 1 (mGluR1). It shows potent antagonistic activity and similar pharmacology across human, mouse, and rat recombinant receptors. Supplied for research use only, it is intended for in vitro and in vivo pharmacology and signaling studies.

• Selective allosteric mGluR1 antagonist
• Potent activity (IC50 5.8 nM for human mGluR1a)
• Cross-species activity (human, mouse, and rat)
• High purity (99.3%)
• Supplied as small solid quantities or 10 mM solution in DMSO
• Suitable for in vitro and in vivo pharmacology studies

Medchemexpress LLC 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-... | 873551-53-2 | 99.3% | 358.41 g/mol | C18H23FN6O | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

FTIDC is a selective, noncompetitive allosteric antagonist of metabotropic glutamate receptor 1 (mGluR1) intended for research use. It is orally active and demonstrates potent antagonism against recombinant mGluR1, supporting pharmacology and neuroscience studies.

• Potent mGluR1 antagonism (IC50 5.8 nM for human mGluR1a).
• Selective noncompetitive allosteric mechanism.
• High chemical purity suitable for research applications.
• Defined physicochemical properties: C18H23FN6O; MW 358.41 g/mol; CAS 873551-53-2.
• Supplied in small-scale quantities appropriate for laboratory experiments.